These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 17964711)
41. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry. Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512 [TBL] [Abstract][Full Text] [Related]
42. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease. Kim H; Lee HK; Han K; Jeon HK Ann Clin Lab Sci; 2009; 39(3):289-94. PubMed ID: 19667414 [TBL] [Abstract][Full Text] [Related]
43. "Aspirin resistance" in ischemic stroke: insights using short thrombelastography. Sambu N; Radhakrishnan A; Englyst N; Weir N; Curzen N J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1412-9. PubMed ID: 23838032 [TBL] [Abstract][Full Text] [Related]
44. Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction. Valles J; Santos MT; Fuset MP; Moscardo A; Ruano M; Perez F; Piñon M; Breña S; Aznar J Am J Cardiol; 2007 Jan; 99(1):19-25. PubMed ID: 17196455 [TBL] [Abstract][Full Text] [Related]
45. Prevalence and biologic profile of aspirin resistance in patients with angiographically proven coronary artery disease. Narvaez I; Sagastagoitia JD; Vacas M; Saez Y; Lafita M; Monica S; de Lafuente JP; Molinero E; Iriarte JA Thromb Res; 2007; 120(5):671-7. PubMed ID: 17331566 [TBL] [Abstract][Full Text] [Related]
46. [Attempts for aspirin monitoring with a new assay system, Ultegra Rapid Platelet Function Assay (RPFA), based on turbidimetric platelet agglutination of whole blood samples]. Satoh K; Ozaki Y Rinsho Byori; 2006 Jun; 54(6):576-82. PubMed ID: 16872006 [TBL] [Abstract][Full Text] [Related]
47. Aspirin resistance in stroke: 2004. Sztriha LK; Sas K; Vecsei L J Neurol Sci; 2005 Mar; 229-230():163-9. PubMed ID: 15760636 [TBL] [Abstract][Full Text] [Related]
48. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Blais N; Pharand C; Lordkipanidzé M; Sia YK; Merhi Y; Diodati JG Thromb Haemost; 2009 Aug; 102(2):404-11. PubMed ID: 19652893 [TBL] [Abstract][Full Text] [Related]
49. Aspirin resistance: what the cardiologist needs to know? Tousoulis D; Siasos G; Stefanadis C Int J Cardiol; 2009 Feb; 132(2):153-6. PubMed ID: 19167101 [TBL] [Abstract][Full Text] [Related]
50. [Aspirin resistance in patients taking small dose of aspirin]. Wang CB; Hu DY; Shi XB; Zhu ZY; Zhu JY; Yang JG Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):219-23. PubMed ID: 16647012 [TBL] [Abstract][Full Text] [Related]
51. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study. Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759 [TBL] [Abstract][Full Text] [Related]
52. Report: frequency of aspirin resistance in patients with coronory artery disease in Pakistan. Akhtar N; Junaid A; Khalid A; Ahmed W; Shah MA; Rahman H Pak J Pharm Sci; 2009 Apr; 22(2):230-3. PubMed ID: 19339237 [TBL] [Abstract][Full Text] [Related]
53. Effect of aspirin on lipoprotein(a) in patients with ischemic stroke. Ranga GS; Kalra OP; Tandon H; Gambhir JK; Mehrotra G J Stroke Cerebrovasc Dis; 2007; 16(5):220-4. PubMed ID: 17845920 [TBL] [Abstract][Full Text] [Related]
55. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899 [TBL] [Abstract][Full Text] [Related]
56. Frequency of aspirin resistance in a community hospital. Mirkhel A; Peyster E; Sundeen J; Greene L; Michelson AD; Hasan A; Domanski M Am J Cardiol; 2006 Sep; 98(5):577-9. PubMed ID: 16923439 [TBL] [Abstract][Full Text] [Related]
57. [A current problem in atherothrombotic diseases--aspirin resistance: definition, mechanisms, determination with laboratory tests and clinical implications]. Pamukçu B; Oflaz H; Nişanci Y Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():20-6. PubMed ID: 18160363 [TBL] [Abstract][Full Text] [Related]
58. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience. Suri MF; Hussein HM; Abdelmoula MM; Divani AA; Qureshi AI Med Sci Monit; 2008 Oct; 14(10):PI39-44. PubMed ID: 18830204 [TBL] [Abstract][Full Text] [Related]
59. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis? von Lewinski F; Riggert J; Paulus W J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186 [TBL] [Abstract][Full Text] [Related]
60. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease. Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]